Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of life comparison of insulin glargine versus NPH insulin in insulin-naive adults with type 2 diabetes
2009-010913-59Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin isophane in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: Health Assessment, Patient treatment satisfaction and Quality-of-Life. Started Apr 2009; status: completed.
02
Drugs
insulin glargineinsulin isophane
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-010913-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010913-59.